Skip to main content
. Author manuscript; available in PMC: 2012 Aug 11.
Published in final edited form as: J Med Chem. 2011 Jul 14;54(15):5307–5319. doi: 10.1021/jm200004e

Figure 3.

Figure 3

Inhibition of E-rosette formation by synthetic peptide 6 derived from CD2 protein. Peptides were added to AET-treated sheep red blood cells (SRBC) (expressing CD58 protein) first and Jurkat cells (expressing CD2 protein) labeled with BCECF was added later. Cells with five or more SRBC bound were counted as rosettes. Values are percent inhibition of peptide-treated cells and are expressed as the mean of three experimental values. Error bars represent standard error of the mean (SEM).